Evidence map›Paper›PMID 37686088›Full record

ReviewInternational journal of molecular sciences2023

Promising Anti-Inflammatory Tools: Biomedical Efficacy of Lipoxins and Their Synthetic Pathways.

Junxi Chi, Jiahao Cheng, Shang Wang, Cheng Li, Ming Chen

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Lipid metabolism, microglia, and stroke.Neural regeneration research · 2026
    Article
  3. Article
  4. Review
  5. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Review
  8. Lipoxin A4 AttenuatesJournal of inflammation research · 2026
    Article
  9. Maresin 1 modulates renal and cardiac lipid profiles in hypertensive rats.American journal of physiology. Renal physiology · 2025
    Article
  10. Review
  11. Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Junxi ChiSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China.
Jiahao ChengSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China.
Shang WangSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China.
Cheng LiSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China.
Ming ChenSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China.
Dalian Polytechnic University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipoxins (LXs) have attracted widespread attention as a class of anti-inflammatory lipid mediators that are produced endogenously by the organism. LXs are arachidonic acid (ARA) derivatives that include four different structures: lipoxin A4 (LXA4), lipoxin B4 (LXB4), and the aspirin-induced differential isomers 15-epi-LXA4 and 15-epi-LXB4. Because of their unique biological activity of reducing inflammation in the body, LXs have great potential for neuroprotection, anti-inflammatory treatment of COVID-19, and other related diseases. The synthesis of LXs in vivo is achieved through the action of lipoxygenase (LO). As a kind of important enzyme, LO plays a major role in the physiological processes of living organisms in mammals and functions in some bacteria and fungi. This suggests new options for the synthesis of LXs in vitro. Meanwhile, there are other chemical and biochemical methods to synthesize LXs. In this review, the recent progress on physiological activity and synthetic pathways of LXs is summarized, and new insights into the synthesis of LXs in vitro are provided.

Indexed as

COVID-19LipoxinsAnimalsAnti-Inflammatory AgentsAspirinInflammationMammalsAnti-Inflammatory AgentsAspirinLipoxinsanti-inflammatory mediatorsbiological activitylipoxinslipoxygenasesynthetic pathways

Identifiers

PMID37686088
PMCPMC10487465
OpenAlexW4386221477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.